Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐blind, placebo‐controlled, clinical study

PD01-01 RESULTS FROM A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE EFFICACY AND SAFETY OF INTRA-TRIGONAL INJECTION OF ONABOTULINUM TOXIN A IN PATIENTS WITH BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS.

10.1016/j.juro.2017.02.181 ◽

2017 ◽

Vol 197 (4S) ◽

Cited By ~ 1

Author(s):

Rui Pinto ◽

Daniel Costa ◽

Afonso Morgado ◽

Pedro Pereira ◽

João Silva ◽

...

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Efficacy And Safety ◽

Toxin A ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo ◽

Onabotulinum Toxin A

Faculty of 1000 evaluation for A Randomized, Double-Blind, Placebo Controlled Trial of Adalimumab in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718022125.793480106 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Intravesical botulinum toxin-a injections reduce bladder pain of interstitial cystitis/ bladder pain syndrome refractory to conventional treatment – a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial

Urological Science ◽

10.1016/j.urols.2015.06.277 ◽

2015 ◽

Vol 26 (2) ◽

pp. S22 ◽

Cited By ~ 1

Author(s):

Yuan-Hong Jiang ◽

Hann-Chorng Kuo

Keyword(s):

Clinical Trial ◽

Botulinum Toxin ◽

Conventional Treatment ◽

Botulinum Toxin A ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Bladder Pain ◽

Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial

Neurourology and Urodynamics ◽

10.1002/nau.22760 ◽

2015 ◽

Vol 35 (5) ◽

pp. 609-614 ◽

Cited By ~ 52

Author(s):

Hann-Chorng Kuo ◽

Yuan-Hong Jiang ◽

Yao-Chou Tsai ◽

Yuh-Chen Kuo

Keyword(s):

Clinical Trial ◽

Botulinum Toxin ◽

Conventional Treatment ◽

Botulinum Toxin A ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Bladder Pain ◽

PD9-11 A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF ADALIMUMAB IN THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

10.1016/j.juro.2014.02.793 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Philip Bosch

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

821 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA TRIAL OF A CA 2+ CHANNEL α2Δ LIGAND, PD-0299685, FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

10.1016/j.juro.2012.02.911 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

J. Curtis Nickel ◽

Anna Crossland ◽

Edward Davis ◽

Francois Haab ◽

Ian Mills ◽

...

Keyword(s):

Interstitial Cystitis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome

European Urology ◽

10.1016/j.eururo.2018.07.026 ◽

2018 ◽

Vol 74 (5) ◽

pp. 623-630 ◽

Cited By ~ 14

Author(s):

Philip C. Bosch

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Faculty Opinions recommendation of A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718022125.793482012 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis

Urology ◽

10.1016/j.urology.2018.11.037 ◽

2019 ◽

Vol 125 ◽

pp. 50-57 ◽

Cited By ~ 1

Author(s):

Hyun Young Lee ◽

Seung Whan Doo ◽

Won Jae Yang ◽

Yun Seob Song ◽

Hwa Yeon Sun ◽

...

Keyword(s):

Systematic Review ◽

Overactive Bladder ◽

Interstitial Cystitis ◽

Meta Analysis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Intravesical Instillation ◽

Efficacy And Safety ◽

Bladder Pain ◽

Onabotulinum Toxin A

Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study

10.1016/j.juro.2014.09.036 ◽

2015 ◽

Vol 193 (3) ◽

pp. 857-862 ◽

Cited By ~ 50

Author(s):

J. Curtis Nickel ◽

Sender Herschorn ◽

Kristene E. Whitmore ◽

John B. Forrest ◽

Peter Hu ◽

...

Keyword(s):

Interstitial Cystitis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Controlled Study ◽

Pentosan Polysulfate ◽

Double Blind ◽

Bladder Pain ◽